You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › June › 24
Cigna
13 months ago
Cigna accused Bristol Myers Squibb of violating antitrust law by keeping generic versions of its blood cancer drug Pomalyst off the market to retain a monopoly.
page 1 of 1